FY26 DOD and HHS appropriations and medical research
2025 · 3rd Quarter (July 1 - Sep 30)
GLAXOSMITHKLINE LLC
Filed by ALPINE GROUP PARTNERS, LLC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ALPINE GROUP PARTNERS, LLC.
- Client
- GLAXOSMITHKLINE LLC
- Filing UUID
- a30713a3-9de7-418d-b068-6c4dacade665
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to prescription drug pricing Issues related to Pharmacy Benefit Managers
Implementation of the Inflation Reduction Act (PL 117-169) Issues related to the reauthorization of the Pandemic All Hazards Preparedness Act Issues related to Pharmacy Benefit Managers Issues related to supply chains
Issues related to intellectual property protections
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.